Reanen Michael, DPM
Foot & Ankle Surgery · Omaha, NENPI 1801228952
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,751 of the $3,655 with a category attached, or 75.3%. 12 manufacturers reported payments, led by Organogenesis Inc. at 30.5% of the total. 2025 is the largest year on record at $1,824, 4.5 times the $401 reported in 2019. That places this record below the midpoint for foot & ankle surgery clinicians in NE, where the typical reported total is $5,810.
Across 68 payments — averaging $53.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- Treace Medical Concepts, Inc.$814
- Kerecis Limited$690
- Acera Surgical, Inc.$190
- Stryker$179
- Integra Lifesciences Corporation$129
- plus $537 from 6 others
What the payments were for
- Speaking & faculty fees$902%
- Travel & lodging$81422%
- Food & beverage$2,75175%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 34 | $1,116 |
| Treace Medical Concepts, Inc. | 2 | $814 |
| Kerecis Limited | 14 | $690 |
| Acera Surgical, Inc. | 3 | $190 |
| Stryker | 4 | $179 |
| Integra Lifesciences Corporation | 2 | $129 |
| Zimmer Biomet | 1 | $122 |
| Avinger Inc. | 1 | $118 |
| Smith+Nephew | 2 | $113 |
| Xeris Pharmaceuticals, Inc. | 1 | $110 |
| Paratek Pharmaceuticals, Inc. | 3 | $57 |
| Solventum Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,655 in reported general payments places this provider in the 35th percentile of 43 foot & ankle surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 64 | $456 |
| Doxycycline Hyclate | 26 | $221 |
| Gabapentin | 19 | $168 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $102 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $96 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $92 |
| Meloxicam | 36 | $77 |
| Prednisone | 19 | $29 |
| Tramadol Hcl | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Omaha
- Bradley CoppleOmaha$83K
- Robert GreenhagenOmaha$29K
- Patrick NelsonOmaha$28K
- Jonathan RouseOmaha$20K
- Scott NelsonOmaha$16K
- Jordan SikesOmaha$15K
- Shannon LensingOmaha$11K
- Jorge AmaroOmaha$10K
- Kevin GrosshansOmaha$8K
- Kent DinucciOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.